News blog

More big pharma moves in the cannabis arena

Novartis is paying out at least $5 million to get into the cannabinoid arena by linking up with UK company GW Pharmaceuticals.

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE